Dinutuximab beta effectively treats Ewing sarcoma when combined with chemotherapy.

Summary: Ewing sarcoma is a rare and dangerous cancer of the bones and soft tissues that mostly affects children and young adults. When this cancer spreads or comes back, it is very hard to treat with standard methods. However, doctors have found a new hope! The cancer cells have a specific target on their surface called GD2. By using a special immune-boosting drug called dinutuximab beta along with regular chemotherapy, doctors can effectively attack and treat this tough cancer.